Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Cancer Res ; 62(4): 1050-6, 2002 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-11861381

RESUMO

We have demonstrated previously the ability of apoptotic cells to prime a functional immune response using an i.p. vaccination protocol with apoptotic cells and interleukin 2, before injecting a lethal dose of tumor cells into syngeneic rats. This protocol resulted in a survival rate of 33%. To elucidate the nature and the activity of the phagocytes involved in the clearance of apoptotic cells in vivo, we modulated the peritoneal cavity environment by administrating either thioglycollate or silica i.p. before injecting the apoptotic cells. Our results showed that thioglycollate abrogated vaccination efficiency, because none of the rats survived under these conditions. In fact, thioglycollate treatment induced a massive recruitment and activation of inflammatory macrophages that efficiently engulfed apoptotic cells, bypassing induction of specific immune responses. In contrast, silica treatment enhanced the vaccination efficiency of apoptotic cells plus interleukin 2 up to 66%. We distinguished a population of dendrite-like cells among the cells derived from the silica-treated peritoneal cavity both by their phenotype (MHC II(+)/CD80(+)/CD86(+)) and by their ability to induce the proliferation of allogeneic T cells in a mixed leukocyte reaction. Our results demonstrate the different roles of macrophages and dendritic-like cells in the physiological clearance of dead tumor cells and their implication in the design of immunomodulating vaccines.


Assuntos
Apoptose/imunologia , Vacinas Anticâncer/imunologia , Neoplasias do Colo/imunologia , Células Dendríticas/imunologia , Dióxido de Silício/farmacologia , Animais , Neoplasias do Colo/terapia , Células Dendríticas/efeitos dos fármacos , Antígenos de Histocompatibilidade Classe II/imunologia , Imunoterapia Adotiva , Interleucina-2/imunologia , Interleucina-2/farmacologia , Ativação Linfocitária/imunologia , Cavidade Peritoneal/citologia , Fagocitose/imunologia , Ratos , Ratos Endogâmicos Lew , Dióxido de Silício/imunologia , Linfócitos T/imunologia , Tioglicolatos/imunologia , Tioglicolatos/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA